Real‐life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|89|5|565-565

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.89, Iss.5, 2014-05, pp. : 565-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Myelodysplastic Syndromes: A Matter of Life or Death

By  

Acta Haematologica, Vol. 111, Iss. 1-2, 2003-12 ,pp. : 78-99

Karger

Access to resources Recommend Favorite

Serum Ferritin Is an Independent Prognostic Factor in Chinese with Myelodysplastic Syndromes Classified as IPSS Intermediate-1

By  

Acta Haematologica, Vol. 129, Iss. 4, 2013-01 ,pp. : 243-250

Karger

Access to resources Recommend Favorite

Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes: Cytogenetic Characterization

By  

Acta Haematologica, Vol. 128, Iss. 3, 2012-08 ,pp. : 170-177

Karger

Access to resources Recommend Favorite

Profile of azacitidine

By D’’Alòò Francsco   Voso Maria Teresa   Leone Giuseppe  

Therapy, Vol. 2, Iss. 5, 2005-09 ,pp. : 717-731

Future Medicine

Access to resources Recommend Favorite

Rescue Coronary Angiography after Failed Thrombolysis: A Real-Life Experience

By  

Cardiology, Vol. 90, Iss. 1, 1998-08 ,pp. : 48-51

Karger

Access to resources Recommend Favorite